Medtronic (MDT) Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Medtronic (MDT) Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis
Medtronic Inc. (NYSE: MDT) Delayed: 79.27 -0.07 (0.09%)
Previous Close $79.34    52 Week High $89.27 
Open $79.17    52 Week Low $71.03 
Day High $79.87    P/E 22.52 
Day Low $78.30    EPS $3.52 
Volume 10,018,610